Mohamed Mabed
Head of the Bone Marrow Transplantation Unit
Oncology Center, Mansoura University
LiveDNA ID:
20.37547
Employment
Professional Appointments
Head of the Bone Marrow Transplantation Unit
Oncology Center, Mansoura University
Education
Academic Background-
Ph.D. University of Franche-Comte, France Immunobiology | Completed: 2006
Publications (16)
Selected Scholarly Contributions
Potential utility of PPARγ agonists in targeting chronic myeloid leukemia stem cells
2026
Bone Marrow Vacuolization at the Crossroads of Specialties: Molecular Insights and Diagnostic Challenges
2025
Exacerbation of Autoimmune Hemolytic Anemia after COVID-19 in a Relapsed/Refractory Hodgkin Lymphoma Patient: A Case Report
2022
Post-transplantation cyclophosphamide as graft versus host disease prophylaxis in patients with acute leukemia received fully matched allogeneic HSCT or haplo-identical HSCT
2022
Prognostic Significance of Absolute Lymphocyte Count, Absolute Monocyte Count, and Absolute Lymphocyte Count to Absolute Monocyte Count Ratio in Follicular Non-Hodgkin Lymphoma
2020
Investigation of telomeres in Egyptian patients with bone marrow failure
2019
The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia.
Mohamed Mabed
2019
Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients.
Mohamed Mabed
2018
Pregnancy associated acute leukemia: Single center experience.
Mohamed Mabed
2018
Increased expression of costimulatory molecules CD86 and sCTLA-4 in patients with acute lymphoblastic leukemia.
Mohamed Mabed
2014
Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus.
Mohamed Mabed
2012
Imatinib-induced aplastic anemia in a patient with chronic myeloid leukemia.
Mohamed Mabed
2012
The potential utility of bone marrow or umbilical cord blood transplantation for the treatment of type I diabetes mellitus.
Mohamed Mabed
2011
Anticardiolipin antibodies in proliferative diabetic retinopathy: An additional risk factor.
Mohamed Mabed
2009
A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
Mohamed Mabed
2009
2006